J. Bilezikian, L. Bandeira, A. Khan, N. Cusano, and . Hyperparathyroidism, The Lancet. 15 sept 2017

J. Bilezikian, N. Cusano, A. Khan, J. Liu, C. Marcocci et al., Primary hyperparathyroidism, Nat Rev Dis Primer, vol.192, p.16033, 2016.

O. Cope, The Story of Hyperparathyroidism at the Massachusetts General Hospital, New England Journal of Medicine, vol.274, issue.21, pp.1174-82, 1966.
DOI : 10.1056/NEJM196605262742105

F. Albright, J. Aub, and W. Bauer, HYPERPARATHYROIDISM, Journal of the American Medical Association, vol.102, issue.16, pp.1276-87, 1934.
DOI : 10.1001/jama.1934.02750160010003

M. Yeh, P. Ituarte, H. Zhou, S. Nishimoto, I. Liu et al., Incidence and Prevalence of Primary Hyperparathyroidism in a Racially Mixed Population, The Journal of Clinical Endocrinology & Metabolism, vol.98, issue.3, pp.1122-1131, 2013.
DOI : 10.1210/jc.2012-4022

URL : https://academic.oup.com/jcem/article-pdf/98/3/1122/10420699/jcem1122.pdf

. Sfendocrino, Disponible sur: http://www.sfendocrino.org/article/832/poly2016- item-266-ndash-ue-8-hypercalcemie 7. J-L Wémeau. Hyperparathyroïdie primaire, J Radiol, 2009.

R. Gittes and I. Radde, Experimental Hyperparathyroidism from Multiple Isologous Parathyroid Transplants: Homeostatic Effect of Simultaneous Thyroid Transplants11, Endocrinology, vol.78, issue.5, pp.1015-1038, 1966.
DOI : 10.1210/endo-78-5-1015

R. Rutledge, M. Stiegel, J. Thomas, and R. Wild, The relation of serum calcium and immunoparathormone levels to parathyroid size and weight in primary hyperparathyroidism, Surgery. déc, vol.98, issue.6, pp.1107-1119, 1985.

S. Silverberg, J. Bilezikian, E. Brown, A. Broadus, M. Brennan et al., Direct Comparison In Vivo and In Vitro of Suppressibility of Parathyroid Function by Calcium in Primary Hyperparathyroidism Determinants of parathormone secretion in primary hyperparathyroidism Chromosome mapping of genes on the short arm of human chromosome 11: parathyroid hormone gene is at 11p15 together with the genes for insulin, c-Harvey-ras 1, and beta-hemoglobin, 1?3):89?92. 13. Zabel BU,200?5. 14. A. Hertig, G. Maruani, M. Paillard et P. Houillier. Hyperparathyroïdie primitive. Néphrologie, pp.2000-283, 1979.

A. Arnold, M. Brown, P. Ureña, R. Gaz, E. Sarfati et al., Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia Monoclonality and abnormal parathyroid hormone genes in parathyroid adenomas Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1 Absence of RET proto-oncogene point mutations in sporadic hyperplastic and neoplastic lesions of the parathyroid gland Obvious mRNA and protein expression but absence of mutations of the RET proto-oncogene in parathyroid tumors, 658?62. 17314?9. 20. Brown EM, Gamba G, Riccardi D, Lombardi M, Butters R, Kifor O, et al. Cloning and characterization of an extracellular Ca2+-sensing receptor from bovine parathyroid, p.575, 1988.

J. Garrett, I. Capuano, L. Hammerland, B. Hung, E. Brown et al., Molecular Cloning and Functional Expression of Human Parathyroid Calcium Receptor cDNAs, Journal of Biological Chemistry, vol.1, issue.21, p.26
DOI : 10.1172/JCI117062

URL : http://www.jbc.org/content/270/21/12919.full.pdf

M. Bai, Structure and function of the extracellular calcium-sensing receptor (Review)., International Journal of Molecular Medicine
DOI : 10.3892/ijmm.4.2.115

M. Bai, S. Trivedi, O. Kifor, S. Quinn, and E. Brown, Intermolecular interactions between dimeric calcium-sensing receptor monomers are important for its normal function, ):2834?9. 24. Brown EM, MacLeod RJ. Extracellular Calcium Sensing and Extracellular Calcium Signaling, 1999.
DOI : 10.1016/S0014-5793(98)01165-X

URL : http://www.pnas.org/content/96/6/2834.full.pdf

R. Chen and W. Goodman, Role of the calcium-sensing receptor in parathyroid gland physiology, American Journal of Physiology-Renal Physiology, vol.286, issue.6, pp.1005-1011, 2004.
DOI : 10.1074/jbc.M200976200

S. Pearce, D. Trump, C. Wooding, G. Besser, S. Chew et al., Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism., Journal of Clinical Investigation, vol.96, issue.6, pp.2683-92, 1995.
DOI : 10.1172/JCI118335

URL : http://www.jci.org/articles/view/118335/files/pdf

C. Ho, D. Conner, M. Pollak, D. Ladd, O. Kifor et al., A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism, Nature Genetics, vol.10, issue.4, p.389, 1995.
DOI : 10.1056/NEJM198202043060502

R. Thakker, The calcium sensing receptor, Bone, vol.47, issue.2, pp.213-219, 2012.
DOI : 10.1016/j.bone.2010.04.032

M. Fadil, *. Hannan, 1. , M. A. Nesbit, *. et al., A homozygous inacrvarng calcium-sensing receptor mutation, Pro339Thr, is associated with isolated primary hyperparathyroidism: correlation between location of mutations and severity of hypercalcaemia, Clin Endocrinol, vol.1, issue.73, pp.715-722, 2010.

S. Silverberg, M. Walker, J. Bilezikian, . Asymptomatic-primary-hyperparathyroidism, J. Clin-densitom-off et al., 14?21. 33 Renal manifestations of primary hyperparathyroidism Bone disease in primary hyperparathyroidism Nephrolithiasis and bone involvement in primary hyperparathyroidism Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery Non-traditional Manifestations of Primary Hyperparathyroidism Carotid Vascular Abnormalities in Primary Hyperparathyroidism, Indian J Endocrinol Metab. mars Arq Bras Endocrinol Metabol. juill Am J Med. sept J Clin Endocrinol Metab. mars N Engl J Med. 21 oct J Clin Densitom Off J Int Soc Clin Densitom. J Clin Endocrinol Metab. oct, vol.16165889803411694, issue.1253317110, pp.258-62, 1990.

S. Iwata, M. D. Walker, M. R. Di-tullio, E. Hyodo, Z. Jin et al., Aortic Valve Calcification in Mild Primary Hyperparathyroidism, The Journal of Clinical Endocrinology & Metabolism, vol.97, issue.1, pp.971132-137, 2012.
DOI : 10.1210/jc.2011-2107

URL : https://doi.org/10.1016/s0735-1097(11)61313-2

P. Numann, A. Torppa, A. Blumetti, M. Walker, D. Mcmahon et al., Neuropsychologic deficits associated with primary hyperparathyroidism Neuropsychological features in primary hyperparathyroidism: a prospective study Prospective evaluation of quality of life (SF-36v2) and nonspecific symptoms before and after cure of primary hyperparathyroidism (1-year follow-up). Surgery. 1 févr Health status improvement after surgical correction of primary hyperparathyroidism in patients with high and low preoperative calcium levels Neuropsychiatric and cognitive changes after surgery for primary hyperparathyroidism, ):1951?8. 43. Caillard C, pp.153-60, 1984.

B. Patten, Neuromuscular Disease in Primary Hyperparathyroidism, Annals of Internal Medicine, vol.80, issue.2, p.182, 1974.
DOI : 10.7326/0003-4819-80-2-182

J. Souberbielle and M. Courbebaisse, ??quilibre phosphocalcique??: r??gulation et explorations, EMC - Endocrinologie - Nutrition, vol.6, issue.3
DOI : 10.1016/S1155-1941(09)49500-3

E. Nussbaum, S. Zahradnik, R. Lavigne, J. Brennan, G. Nozawa-ung et al., 1?14. 48 Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia, janv Clin Chem. 1 août J Clin Endocrinol Metab. juill, vol.63375, issue.381, pp.1364-1371, 1987.

C. Lazure and P. , A non-(1?84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples

P. Gao, S. Scheibel, D. Amour, P. John, M. Rao et al., Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: implications for improvement of accurate assessment of parathyroid function J Bone Miner Res Off J Am Soc Bone Miner Res Structure of non-(1-84) PTH fragments secreted by parathyroid glands in primary and secondary hyperparathyroidism Amino-terminal form of parathyroid hormone (PTH) with immunologic similarities to hPTH(1-84) is overproduced in primary and secondary hyperparathyroidism, ):998?1007. 53. D'Amour, pp.2037-2081, 2001.

M. Rubin, S. Silverberg, D. Amour, P. Brossard, J. Rousseau et al., An N-Terminal Molecular Form of Parathyroid Hormone (PTH) Distinct from hPTH(1?84) Is Overproduced in Parathyroid Carcinoma Clinical utility of an immunoradiometric assay for parathyroid hormone (1-84) in primary hyperparathyroidism Potential Clinical Utility of a New IRMA for Parathyroid Hormone in Postmenopausal Patients with Primary Hyperparathyroidism Third-or secondgeneration parathyroid hormone assays: a remaining debate in the diagnosis of primary hyperparathyroidism, ):1470?6. 55. Silverberg SJ4725?30. 56. Vincenzo Carnevale,1 Simona Dionisi,2 Italo Nofroni,3 Elisabetta Romagnoli,2, Federica Paglia,2 Simona De Geronimo,2 Jessica Pepe,2 Giovanni Clemente, pp.6370-6372, 2003.

J. Souberbielle, G. Friedlander, C. Cormier, M. Holick, T. Chen et al., Practical considerations in PTH testing Vitamin D and skin physiology: a D-lightful story, Clin Chim Acta Int J Clin Chem. avr J Bone Miner Res Off J Am Soc Bone Miner Res. déc, vol.36622, issue.59 2, pp.28-33, 2006.

J. Souberbielle, Actualités sur la vitamine D, 2014.
DOI : 10.1051/ocl/2013059

URL : http://www.ocl-journal.org/articles/ocl/pdf/2014/03/ocl130040.pdf

B. Hollis, Editorial: The Determination of Circulating 25-Hydroxyvitamin D: No Easy Task, The Journal of Clinical Endocrinology & Metabolism, vol.89, issue.7
DOI : 10.1210/jc.2004-0682

URL : https://academic.oup.com/jcem/article-pdf/89/7/3149/10742570/jcem3149.pdf

P. Sluss, L. Thienpont, F. Velayoudom-cephise, L. Foucan, B. Soudan et al., Specifications for trueness and precision of a reference measurement system for serum/plasma 25-hydroxyvitamin D analysisHalf of the patients with primary hyperparathyroidisms have a vitamin D deficiency: aggravating the osseous attack, Presse Medicale Paris Fr, pp.120-127, 1983.

B. Dawson-hughes, R. Heaney, M. Holick, P. Lips, P. Meunier et al., Estimates of optimal vitamin D status Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know, juill J Clin Endocrinol Metab. janv, vol.1696, issue.71, pp.713-719, 2005.

J. Adams and M. Hewison, Update in Vitamin D, The Journal of Clinical Endocrinology & Metabolism, vol.95, issue.2, pp.471-479, 2010.
DOI : 10.1210/jc.2009-1773

H. Bischoff-ferrari, E. Giovannucci, W. Willett, T. Dietrich, D. Blópez et al., Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes EMAS position statement: Vitamin D and postmenopausal health Primary hyperparathyroidism: diagnosis, evaluation, and treatment, Am J Clin Nutr. juill Maturitas. janv Bilezikian JP Curr Opin Endocrinol Diabetes Obes. déc, vol.847111, issue.706, p.345, 2004.

R. Gasser, Klinische Aspekte des prim??ren Hyperparathyreoidismus: klinische Symptomatik, Diagnose und Therapie, Wiener Medizinische Wochenschrift, vol.88, issue.17-18, pp.397-402, 1946.
DOI : 10.1210/jc.2002-020667

P. Fardellone, J. Sebert, M. Bouraya, O. Bonidan, G. Leclercq et al., Evaluation of the calcium content of diet by frequential self-questionnaire] Factors contributing to negative parathyroid localization: an analysis of 1000 patients, ):99?103. 73. V. Lapras,74?9. 75. Coakley AJ, pp.791-795, 1989.

B. Richard, Hyperparathyroïdie primaire : échographie et scintigraphie 17 avr Indications et stratégies d'utilisation des principaux examens d'imagerie: Imagerie parathyroidienne, J Radiol, vol.77, pp.397-408, 2009.

B. Shafiei, S. Hoseinzadeh, F. Fotouhi, H. Malek, F. Azizi et al., Preoperative 99 mTcsestamibi scintigraphy in patients with primary hyperparathyroidism and concomitant nodular goiter: comparison of Single photon emission computed tomography (SPECT) should be routinely performed for the detection of parathyroid abnormalities utilizing technetium-99m sestamibi parathyroid scintigraphy, ):1070?6. 79651?5. 80. Rodgers SE, Hunter GJ, Hamberg LM et al. Accuracy of 2-Phase Parathyroid CT for the Preoperative Localization of Parathyroid Adenomas in Primary Hyperparathyroidism. AJNR News Digest. 2016. 81. Rodgers SE, Hunter GJ, Hamberg LM, 2009.

O. Ernst, Improved preoperative planning for directed parathyroidectomy with 4-dimensional computed tomography, Surgery. déc, vol.140, issue.6, 2006.

M. Hodolic, V. Huchet, S. Balogova, L. Michaud, K. Kerrou et al., Incidental uptake of 18F-fluorocholine (FCH) in the head or in the neck of patients with prostate cancer, Radiology and Oncology, vol.48, issue.3, pp.228-262, 2014.
DOI : 10.2478/raon-2013-0075

T. Positron-emission, Computerized Tomography a New Imaging Tool for Detecting Hyperfunctioning Parathyroid Glands in Primary or Secondary Hyperparathyroidism?, J Clin Endocrinol Metab. 1 déc, vol.99, issue.12, pp.4531-4537, 2014.

D. Prié, P. Torres, G. Friedlander, I. Ben-dov, H. Galitzer et al., Un nouveau système de régulation du bilan du phosphate : Fibroblast Growth Factor 23-Klotho. Néphrologie Thérapeutique -Vol 5 -N° 6 -P 513-519 The parathyroid is a target organ for FGF23 in rats, 4003?8. 87. C. Cormier. Hyperparathyroïdies primitive et secondaire, 2007.

S. Wilhelm, T. Wang, D. Ruan, J. Lee, S. Asa et al., The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism, JAMA Surgery, vol.151, issue.10, pp.959-68, 2016.
DOI : 10.1001/jamasurg.2016.2310

L. Morris, J. Zelada, B. Wu, T. Hahn, and M. Yeh, Parathyroid Surgery in the Elderly, The Oncologist, vol.15, issue.12, pp.1273-84, 2010.
DOI : 10.1634/theoncologist.2010-0158

URL : http://theoncologist.alphamedpress.org/content/15/12/1273.full.pdf

M. Rubin, J. Bilezikian, D. Mcmahon, T. Jacobs, E. Shane et al., The Natural History of Primary Hyperparathyroidism with or without Parathyroid Surgery after 15 Years):3462?70. 91. NIH conference. Diagnosis and management of asymptomatic primary hyperparathyroidism: consensus development conference statement, J Clin Endocrinol Metab. sept Ann Intern Med. 1 avr, vol.93114, issue.97, pp.593-600, 1991.

H. Autorité-de-santé, -. Nemeth, E. Shoback, D. Nemeth, E. Heaton et al., Disponible sur: https://www.hassante .fr/portail/jcms/c_750917/en/mimpara 93 Calcimimetic and calcilytic drugs for treating bone and mineralrelated disorders, 373?84. 94, 2013.

M. Peacock, J. P. Bilezikian, P. S. Klassen, M. D. Guo, S. A. Turner et al., Cinacalcet Hydrochloride Maintains Long-Term Normocalcemia in Patients with Primary Hyperparathyroidism Cinacalcet treatment of primary hyperparathyroidism: biochemical and bone densitometric outcomes in a fiveyear study Cinacalcet HCl Reduces Hypercalcemia in Primary Hyperparathyroidism across a Wide Spectrum of Disease Severity, 4860?7. 97. Peacock M, pp.627-662, 2004.

M. Filopanti, U. Verga, F. Ermetici, L. Olgiati, C. Eller-vainicher et al., MEN1-related hyperparathyroidism: response to cinacalcet and its relationship with the calcium-sensing receptor gene variant Arg990Gly Clinical Use of Cinacalcet in MEN1 Hyperparathyroidism, 157?64. 99. Moyes VJ, 2010.

F. Saponaro, A. Faggiano, F. Grimaldi, G. Borretta, M. Brandi et al., Cinacalcet in the management of primary hyperparathyroidism: post marketing experience of an Italian multicentre group, Clinical Endocrinology, vol.39, issue.1, pp.20-26, 2013.
DOI : 10.1007/s12020-011-9459-0

S. Silverberg and J. Bilezikian, ???Incipient??? Primary Hyperparathyroidism: A ???Forme Fruste??? of an Old Disease, The Journal of Clinical Endocrinology & Metabolism, vol.88, issue.11, pp.5348-52, 2003.
DOI : 10.1210/jc.2003-031014

URL : https://academic.oup.com/jcem/article-pdf/88/11/5348/9062239/jcem5348.pdf

A. Parfitt, D. Rao, and M. Kleerekoper, Asymptomatic primary hyperparathyroidism discovered by multichannel biochemical screening: Clinical course and considerations bearing on the need for surgical intervention, Journal of Bone and Mineral Research, vol.314, issue.2, pp.97-101, 1991.
DOI : 10.7326/0003-4819-109-12-959

URL : http://onlinelibrary.wiley.com/doi/10.1002/jbmr.5650061421/pdf

. Normocalcaemic, vitamin D-sufficient hyperparathyroidism -high prevalence and low morbidity in the general population: A long-term follow-up study, the WHO MONICA project, Clin Endocrinol (Oxf). août, vol.83, issue.2, pp.277-84, 2015.

D. Rao, R. Wilson, M. Kleerekoper, and A. Parfitt, Lack of Biochemical Progression or Continuation of Accelerated Bone Loss in Mild Asymptomatic Primary Hyperparathyroidism: Evidence for Biphasic Disease Course, The Journal of Clinical Endocrinology & Metabolism, vol.67, issue.6, pp.1294-1302, 1988.
DOI : 10.1210/jcem-67-6-1294

E. Lundgren, P. Ridefelt, G. Åkerström, S. Ljunghall, and J. Rastad, Parathyroid Tissue in Normocalcemic and Hypercalcemic Primary Hyperparathyroidism Recruited by Health Screening, World Journal of Surgery, vol.20, issue.7
DOI : 10.1007/s002689900111

G. Maruani and A. Hertig, Normocalcemic Primary Hyperparathyroidism: Evidence for a Generalized Target-Tissue Resistance to Parathyroid Hormone, The Journal of Clinical Endocrinology & Metabolism, vol.88, issue.10, pp.88104641-4648, 2003.
DOI : 10.1210/jc.2002-021404

URL : https://academic.oup.com/jcem/article-pdf/88/10/4641/10403205/jcem4641.pdf

F. Cosman, V. Shen, F. Xie, M. Seibel, A. Ratcliffe et al., Estrogen Protection against Bone Resorbing Effects of Parathyroid Hormone Infusion: Assessment by Use of Biochemical Markers, Annals of Internal Medicine, vol.118, issue.5, pp.337-380, 1993.
DOI : 10.7326/0003-4819-118-5-199303010-00003

P. Selby and M. Peacock, Ethinyl Estradiol and Norethindrone in the Treatment of Primary Hyperparathyroidism in Postmenopausal Women, New England Journal of Medicine, vol.314, issue.23, pp.1481-1486, 1986.
DOI : 10.1056/NEJM198606053142304

A. García-martín, R. Reyes-garcía, and M. Muñoz-torres, Normocalcemic primary hyperparathyroidism: one-year follow-up in one hundred postmenopausal women, Endocrine, vol.94, issue.3, pp.764-770, 2012.
DOI : 10.1210/jc.2008-1760

K. Tordjman, Y. Greenman, E. Osher, G. Shenkerman, and N. Stern, Characterization of normocalcemic primary hyperparathyroidism, The American Journal of Medicine, vol.117, issue.11, pp.861-864, 2004.
DOI : 10.1016/j.amjmed.2004.06.037

H. Lowe, D. Mcmahon, M. Rubin, J. Bilezikian, and S. Silverberg, Normocalcemic Primary Hyperparathyroidism: Further Characterization of a New Clinical Phenotype, The Journal of Clinical Endocrinology & Metabolism, vol.92, issue.8, pp.3001-3006, 2007.
DOI : 10.1210/jc.2006-2802

J. Bilezikian, M. Brandi, R. Eastell, S. Silverberg, R. Udelsman et al., Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Fourth International Workshop, The Journal of Clinical Endocrinology & Metabolism, vol.99, issue.10, pp.3561-3570, 2014.
DOI : 10.1210/jc.2014-1413

R. Sapin, Evaluation of a new PTH assay specific only for the 1-84 PTH, J Clin Endocrinol Metab, pp.88104641-4648, 2008.

E. Cavalier, A. Carlisi, J. Chapelle, and P. Delanaye, False positive PTH results: An easy strategy to test and detect analytical interferences in routine practice, Clinica Chimica Acta, vol.387, issue.1-2, pp.150-152, 2008.
DOI : 10.1016/j.cca.2007.08.019

URL : http://orbi.ulg.ac.be/handle/2268/4108

A. Hollenberg and A. Arnold, Hypercalcemia with low-normal serum intact PTH: A novel presentation of primary hyperparathyroidism, The American Journal of Medicine, vol.91, issue.5, pp.547-555, 1991.
DOI : 10.1016/0002-9343(91)90193-2

G. Carmignani, E. Belgrano, P. Puppo, U. Repetto, M. Giusti et al., PTH Radioimmunoassay and Loading Tests in the Diagnosis of Patients with Primary Hyperparathyroidism, European Urology, vol.8, issue.2
DOI : 10.1159/000473489

J. Howard and T. R. Hopkins, On certain physiologic responsive to intraveinous injection of calcium salts into normal, hyperparathyroid and hypoparathyroid persons, 1953.

F. Cetani, A. Picone, P. Cerrai, E. Vignali, S. Borsari et al., Parathyroid Expression of Calcium-Sensing Receptor Protein and in Vivo Parathyroid Hormone-Ca2+ Set-Point in Patients with Primary Hyperparathyroidism, Journal of Clinical Endocrinology & Metabolism, vol.85, issue.12, pp.4789-94, 2000.
DOI : 10.1210/jc.85.12.4789

M. Cirillo, P. Strazzullo, P. Mattioli, A. Siani, and G. Cioffi, Basal Parathyroid Activity and Renal Calcium Handling during an Intravenous Calcium Load, Nephron, vol.38, issue.3, pp.167-176, 1984.
DOI : 10.1159/000183301

P. Lips, J. Netelenbos, L. Van-doorn, W. Hackeng, and C. Lips, Stimulation and suppression of intact parathyroid hormone (PTH1???84) in normal subjects and hyperparathyroid patients, Clinical Endocrinology, vol.15, issue.1, pp.35-40, 1991.
DOI : 10.7326/0003-4819-91-5-739

I. Titon, A. Cailleux-bounacer, J. Basuyau, H. Lefebvre, A. Savouré et al., Evaluation of a standardized short-time calcium suppression test in healthy subjects: interest for the diagnosis of primary hyperparathyroidism, European Journal of Endocrinology, vol.157, issue.3, pp.351-358, 2007.
DOI : 10.1530/EJE-07-0132

DOI : 10.1016/S0140-6736(71)91510-8

J. Tohme, J. Bilezikian, T. Clemens, S. Silverberg, E. Shane et al., Suppression of Parathyroid Hormone Secretion with Oral Calcium in Normal Subjects and Patients with Primary Hyperparathyroidism*, The Journal of Clinical Endocrinology & Metabolism, vol.70, issue.4, pp.951-957, 1990.
DOI : 10.1210/jcem-70-4-951

J. Monchik, R. Lamberton, and U. Roth, Role of the oral calcium-loading test with measurement of intact parathyroid hormone in the diagnosis of symptomatic subtle primary hyperparathyroidism, Surgery. déc, vol.112, issue.6, pp.1103-1112, 1992.

C. Mchenry, I. Rosen, P. Walfish, and A. Pollard, Oral calcium load test: diagnostic and physiologic implications in hyperparathyroidism, Surgery. déc, vol.108, issue.1032, pp.1026-1057, 1990.

M. Bevilacqua, L. Dominguez, V. Righini, V. Valdes, T. Vago et al., Dissimilar PTH, Gastrin, and Calcitonin Responses to Oral Calcium and Peptones in Hypocalciuric Hypercalcemia, Primary Hyperparathyroidism, and Normal Subjects: A Useful Tool for Differential Diagnosis, Journal of Bone and Mineral Research, vol.292, issue.3, pp.406-418, 2006.
DOI : 10.1152/ajpgi.00283.2002

URL : http://onlinelibrary.wiley.com/doi/10.1359/JBMR.051210/pdf

A. Cailleux, P. Vuillermet, J. Basuyau, J. Ménard, H. Lefebvre et al., A step towards cinacalcet testing for the diagnosis of primary hyperparathyroidism: comparison with the standardized intravenous calcium loading. A pilot study, Clinical Endocrinology, vol.149, issue.5, pp.663-672, 2015.
DOI : 10.1530/eje.0.1490301

. Afssaps, Rapport du contrôle de marché des dispositifs médicaux de diagnostic in vitro de dosage de la parathormone (PTH), 2009.

P. Pfitzenmeyer, P. Manckoundia, P. Goudet, L. Popitean, and I. Martin, L???hyperparathyro??die primaire du sujet ??g?? : il faut continuer ?? la rechercher, NPG Neurologie - Psychiatrie - G??riatrie, vol.4, issue.23, pp.40-43, 2004.
DOI : 10.1016/S1627-4830(04)97973-1

J. Bilezikian, N. Cusano, A. Khan, J. Liu, C. Marcocci et al., Primary hyperparathyroidism, Nature Reviews Disease Primers, vol.82, p.16033, 2016.
DOI : 10.1083/jcb.82.1.93

A. Broadus, J. Mahaffey, F. Bartter, and R. Neer, Nephrogenous Cyclic Adenosine Monophosphate as a Parathyroid Function Test, Journal of Clinical Investigation, vol.60, issue.4, pp.771-83, 1977.
DOI : 10.1172/JCI108831

URL : http://www.jci.org/articles/view/108831/files/pdf

A. Siperstein, E. Berber, R. Mackey, M. Alghoul, K. Wagner et al., Prospective evaluation of sestamibi scan, ultrasonography, and rapid PTH to predict the success of limited exploration for sporadic primary hyperparathyroidism, Surgery, vol.136, issue.4, pp.872-80, 2004.
DOI : 10.1016/j.surg.2004.06.024